Novel Insights into Heterozygous Factor XIII Deficiency.

Abstract excerpt

The prevalence and clinical significance of heterozygous factor XIII (FXIII) deficiency has long been debated, with controversial reports emerging since 1988. In the absence of large epidemiologic studies, but based on a few studies, a prevalence of 1 per 1,000 to 5,000 is estimated. In southeastern Iran, a hotspot area for the disorder, a study of more than 3,500 individuals found an incidence of 3.5%. Between...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Factor XIII
• Share to Blood properties and coagulation
• Share to Factor XIII Deficiency